TÍTULO DE ESPECIALISTA
EN DELIMITACIÓN DE VOLÚMENES

EN LA ERA DE LA INTELIGENCIA ARTIFICIAL Y LAS NUEVAS TECNOLOGÍAS

Dra. Sofía Córdoba Largo

Médico Adjunto de Oncología Radioterápica

HU Puerta de Hierro Majadahonda. Madrid

ACADEMIC DATA
• 1987-1993: Bachelor of Medicine and Surgery, Complutense University, Madrid.
• Medical Specialist in Radiation Oncology: MIR: 1997- 2001. “Clínica Puerta de Hierro” Hospital, Madrid.
• Doctoral Thesis: “Mobile tongue cancer: clinical prognostic factors, tumor oxygenation and cell proliferation.”. Junio 2004. Cum Laude.
• Training Course for Radioactive Facilities Supervisors. Center for Energy, Environmental and Technological Research (CIEMAT). Ramón y Cajal, Hospital, Madrid, May 1996.
• Radioactive Facilities Supervisor License
PROFESSIONAL EXPERIENCE
• Currently: Medical specialist in radiation oncology, Puerta de Hierro , University Hospital, Octubre 2019.
• Abril 2007-Octubre 2019: Medical specialist in radiation oncology Clínico San Carlos Hospital.
• Julio 2003-Marzo 2007: Medical specialist in radiation oncology Ramón y Cajal Hospital.
• Collaborating Professor in Practical Teaching of the DEPARTMENT OF RADIOLOGY AND PHYSICAL MEDICINE, since 2010/2011 to 2019.
• TUTOR FOR RADIATION ONCOLOGY RESIDENTS (Nov/2022 – actual. Clínico San Carlos, Hospital).
• TUTOR FOR RADIATION ONCOLOGY RESIDENTS (03/11/2015 – Octubre 2019. Clínico San Carlos, Hospital). • Collaborating professor in the I and II editions of the Master’s program, “Patient with advanced chronic disease and palliative needs.” Complutense University de Madrid. Curso 2017/2018, 2018/2019, 2021/2022 Y 2022/2023
• Octubre 2001- Diciembre 2003: RESEARCH TRAINING SCHOLARSHIP (BEFI) developed in the Basic Radiobiology Laboratory of the Radiation Oncology Service of the Hospital Universitario Puerta de Hierro through the project: “Study of the radiosensitizing properties of two new marine compounds with cytotoxic activity, exteinascidin-743 and aplidin, in a panel of 6 tumor lines”. Dr Jesús Romero Fernández y and Dr Alejandro de la Torre Tomás.
• Julio 2001- Septiembre 2001: Collaboration with PharmaMar S.A. in the Radiobiology research project: “Radiosensitization by new drugs of marine origin: Ectainiscidin (ET743), Kahalalide (KH) and Aplidine (APL)”.
• Mayo 1997- Mayo 2001: Intern and Resident in Radiation Oncology at the University Hospital “Clínica Puerta de Hierro” in Madrid.
o Three-month rotation at the Department of Clinical Oncology, Christie Hospital and Holt Radium Institute, Manchester, United Kingdom.